Advertisement
U.S. markets closed
Advertisement

Xiao-I Corporation (AIXI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
2.1600-0.2300 (-9.62%)
At close: 03:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close2.3900
Open2.3400
Bid2.2000 x 3000
Ask2.3000 x 1000
Day's Range2.1200 - 2.4900
52 Week Range1.4000 - 10.3900
Volume45,335
Avg. Volume95,823
Market Cap155.621M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AIXI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • XIAO-I Corporation
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Rating
    Fair Value
    Economic Moat
    4 months agoMorningstar
View more